Prostate cancer: Utility of diffusion‐weighted imaging as a marker of side‐specific risk of extracapsular extension

Abstract

PURPOSE: To assess the utility of diffusion-weighted imaging (DWI) findings as an indirect marker of side-specific risk of extracapsular extension (ECE) of prostate cancer. MATERIALS AND METHODS: Fifty-one patients underwent 3T magnetic resonance imaging (MRI) before prostatectomy. Radiologists 1 and 2 (4 and 1 years experience) assessed each side for ECE using T2-weighted imaging (T2WI) and evaluated apparent diffusion coefficient (ADC) maps for the presence of apparent tumor in each lobe and to measure peripheral zone ADC. A uropathologist measured the extent of any ECE. RESULTS: In all, 28/102 lobes had ECE, of which 12 measured ≤1 mm, 11 measured >1 mm and ≤2 mm, and five measured >2 mm. Side-specific accuracies for detection of ECE for readers 1 and 2 were respectively: T2WI 68.6% and 74.5%; presence of apparent tumor on ADC map 66.7% and 60.8%; ADC value 75.5% and 69.6%. For ECE >2 mm, both readers achieved 100% sensitivity based on apparent tumor on ADC map or ADC values and 80% sensitivity using T2WI. For detection of ECE ≤2 mm, sensitivity for all combinations of the three methods and two readers ranged from 58.3%-81.8%, aside from assessment for ECE using T2WI by the less experienced reader, which exhibited sensitivity of 17.4%. Interreader agreement for the presence of ECE was 0.18 using T2WI, 0.37 using apparent tumor on ADC map, and 0.60 using ADC values. CONCLUSION: Compared with T2WI, DWI had comparable accuracy for side-specific assessment of ECE, greater sensitivity for ECE <2 mm for the less-experienced radiologist, and greater interreader agreement.